Leading International Investment Research

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Leading International Investment Research, Edison Investment Research

Cross Asset Strategy

Cross Asset Strategy / Cross Asset Strategy

Vivienne Parry talks to Dr Jim Kuo, CEO & Dr James Gilligan, President

Tryp Therapeutics is a pharmaceutical company focused on identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs.

For more healthcare content, visit: https://www.edisongroup.com/our-content/?sector=healthcare

영상: Tryp Therapeutics - Edison 오픈 하우스 인터뷰